-
UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging
UltraSight™ Secures KFDA Approval for AI-Driven Cardiac Imaging Software in South Korea SEOUL, SOUTH KOREA, June 9, 2025 — UltraSight™, a leader in digital health innovation, announced today that its real-time machine learning guidance software has received regulatory approval from South Korea’s Ministry of Food and Drug Safety (KFDA). The clearance, granted to UltraSight’s joint…